Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment

References

• McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol 1983; 8: 1–16
   PubMed Web of Science ®Google Scholar
• Queiroz-Telles F, McGinnis MR, Salkin I, Graybill JR. Subcutaneous mycoses. Infect Dis Clin North Am 2003; 17: 59–85
   PubMed Web of Science ®Google Scholar
• Revankar SG. Phaeohyphomycosis. Infect Dis Clin North Am 2006; 20: 609–620
   PubMed Web of Science ®Google Scholar
• Silveira F, Nucci M. Emergence of black moulds in fungal disease: epidemiology and therapy. Curr Opin Infect Dis 2001; 14: 679–684
   PubMed Web of Science ®Google Scholar
• Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol 2005; 53: 931–951
   PubMed Web of Science ®Google Scholar
• Castro RM, Castro LG. On the priority of description of chromomycosis. Mykosen 1987; 30: 397–403
   PubMedGoogle Scholar
• Rudolph M. ber die brasilianische ‘Figueira’ (Vorläufige Mitteilung). Archiev Schiffs und Tropen-Hyg 1914; 18: 498–499
   Google Scholar
• Pedroso A GJM. 4 casos de dermatite verrucosa produzida pela Phialophora verrucosa. Ann Paulistas de Medicina e Cirurgia 1920; 11: 53–61
   Google Scholar
• Terra F, Torres M, Fonseca O, Area Leão AE. Novo typo de dermatite verrucosa mycose por Achroteca com associação de leishmaniose. Brazil Med 1922; 36: 363–368
   Google Scholar
• Odds FC, Arai T, Disalvo AF, Evans EG, et al. Nomenclature of fungal diseases: a report and recommendations from a Sub-Committee of the International Society for Human and Animal Mycology (ISHAM). J Med Vet Mycol 1992; 30: 1–10
   PubMedGoogle Scholar
• Rippon JW. Chromoblastomycosis and related dermal infections caused by dematiaceous fungi. Medical Mycology. The Pathogenic Fungi and the Pathogenic Actinomycetes2nd ed. WB Saunders, Philadelphia 1982; 249–276, JW Rippon
   Google Scholar
• Matsumoto T, Matsuda T, McGinnis MR, Ajello L. Clinical and mycological spectra of Wangiella dermatitidis infections. Mycoses 1993; 36: 145–155
   PubMed Web of Science ®Google Scholar
• Ainsworth and Bisby's Dictionary of the Fungi 9th ed. EnghamUK: CABI Bioscience Publishers, 2001.
   Google Scholar
• Hernandez-Hernandez F, Camacho-Arroyo I, Cerbon MA, et al. Sex hormone effects on Phialophora verrucosa in vitro and characterization of progesterone receptors. J Med Vet Mycol 1995; 33: 235–239
   PubMedGoogle Scholar
• Londero AT, Ramos CD. Chromomycosis: a clinical and mycologic study of thirty-five cases observed in the hinterland of Rio Grande do Sul, Brazil. Am J Trop Med Hyg 1976; 25: 132–135
   PubMed Web of Science ®Google Scholar
• Tsuneto LT, Arce-Gomez B, Petzl-Erler ML, Queiroz-Telles F. HLA-A29 and genetic susceptibility to chromoblastomycosis. J Med Vet Mycol 1989; 27: 181–185
   PubMedGoogle Scholar
• Bayles MA. Chromomycosis. In Hay RJ. Baillière's Clinical Tropical Medicine and Comunicable Diseases. Tropical Fungal Infections. London: WB Saunders, 1986: 45–70.
   Google Scholar
• Esterre P, Andriantsimahavandy A, Ramarcel ER, Pecarrere JL. Forty years of chromoblastomycosis in Madagascar: a review. Am J Trop Med Hyg 1996; 55: 45–47
   PubMed Web of Science ®Google Scholar
• Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses 2001; 44: 1–7
   PubMed Web of Science ®Google Scholar
• Minotto R, Bernardi CD, Mallmann LF, Edelweiss MI, Scroferneker ML. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol 2001; 44: 585–592
   PubMed Web of Science ®Google Scholar
• Perez-Blanco M, Hernández Valles R, Garcia-Humbria L, Yegres F. Chromoblastomycosis in children and adolescents in the endemic area of the Falcon State, Venezuela. Med Mycol 2006; 44: 467–471
   PubMed Web of Science ®Google Scholar
• Silva JP, de SW, Rozental S. Chromoblastomycosis: a retrospective study of 325 cases on Amazonic Region (Brazil). Mycopathologia 1998; 143: 171–175
   PubMed Web of Science ®Google Scholar
• Attapattu MC. Chromoblastomycosis – a clinical and mycological study of 71 cases from Sri Lanka. Mycopathologia 1997; 137: 145–151
   PubMed Web of Science ®Google Scholar
• Leslie DF, Beardmore GL. Chromoblastomycosis in Queensland: a retrospective study of 13 cases at the Royal Brisbane Hospital. Australas J Dermatol 1979; 20: 23–30
   Google Scholar
• Rajendran C, Ramesh V, Misra RS, et al. Chromoblastomycosis in India. Int J Dermatol 1997; 36: 29–33
   Google Scholar
• Lopez MR, Mendez Tovar LJ. Chromoblastomycosis. Clin Dermatol 2007; 25: 188–194
   Google Scholar
• Sonck CE. Chromoblastomycosis: five cases from Finland. Acta Derm Venereol 1959; 39: 300–309
   Google Scholar
• Schell WA, Esterre P. Chromoblastomycosis. In: Topley & Wilson. Mycology Reference Book. 10th ed. London: Hodder Arnold; 2006.
   Google Scholar
• Borelli D. Acrotheca aquaspersa nova, new species agent of chromomycosis. Acta Cient Venez 1972; 23: 193–196
   Google Scholar
• Barba-Gomez JF, Mayorga J, McGinnis MR, Gonzalez-Mendoza A. Chromoblastomycosis caused by Exophiala spinifera. J Am Acad Dermatol 1992; 26: 367–370
   PubMed Web of Science ®Google Scholar
• Naka W, Harada T, Nishikawa T, Fukushiro R. A case of chromoblastomycosis: with special reference to the mycology of the isolated Exophiala jeanselmei. Mykosen 1986; 29: 445–452
   PubMedGoogle Scholar
• Padhye AA, Ajello L. A case of chromoblastomycosis with special reference to the mycology of the isolated Exophiala jeanselmei. Mykosen 1987; 30: 134
   PubMedGoogle Scholar
• Chowdhary A, Guarro J, Randhawa HS, Gene J, et al. A rare case of chromoblastomycosis in a renal transplant recipient caused by a non-sporulating species of Rhytidhysteron. Med Mycol 2008; 46: 163–166
   Web of Science ®Google Scholar
• Piepenbring M, Caceres Mendez OA, Espino Espinoza AA, et al. Chromoblastomycosis caused by Chaetomium funicola: a case report from Western Panama. Br J Dermatol 2007; 157: 1025–1029
   Google Scholar
• Redondo-Bellon P, Idoate M, Rubio M, Ignacio HJ. Chromoblastomycosis produced by Aureobasidium pullulans in an immunosuppressed patient. Arch Dermatol 1997; 133: 663–664
   PubMedGoogle Scholar
• Harada S, Ueda T, Kusunoki T. Systemic chromomycosis. J Dermatol 1976; 3: 13–17
   Google Scholar
• Salem FA, Kannangara DW, Nachum R. Cerebral chromomycosis. Arch Neurol 1983; 40: 173–174
   Google Scholar
• Vyas MC, Joshi YR, Bhargava N, Joshi KR, Tanwar RK. Cerebral chromoblastomicosis – a rare case report of cerebral abscess and brief review of literature – a case report. Indian J Pathol Microbiol 2000; 43: 81–85
   PubMedGoogle Scholar
• Wackym PA, Gray GF, Jr, Richie RE, Gregg CR. Cutaneous chromomycosis in renal transplant recipients. Successful management in two cases. Arch Intern Med 1985; 145: 1036–1037
   Google Scholar
• de Hoog GS, Queiroz-Telles F, Haase G, et al. Black fungi: clinical and pathogenic approaches. Med Mycol 2000; 38(Suppl. 1)243–250
   Google Scholar
• Esterre P, Queiroz-Telles F. Management of chromoblastomycosis: novel perspectives. Curr Opin Infect Dis 2006; 19: 148–152
   PubMed Web of Science ®Google Scholar
• De Hoog GS, Attili-Angelis D, Vicente VA, Van Den Ende AH, Queiroz-Telles F. Molecular ecology and pathogenic potential of Fonsecaea species. Med Mycol 2004; 42: 405–416
   PubMed Web of Science ®Google Scholar
• Takei H, Goodman JC, Powell SZ. Cerebral phaeohyphomycosis caused by Cladophialophora bantiana and Fonsecaea monophora: report of three cases. Clin Neuropathol 2007; 26: 21–27
   Google Scholar
• Surash S, Tyagi A, De Hoog GS, et al. Cerebral phaeohyphomycosis caused by Fonsecaea monophora. Med Mycol 2005; 43: 465–472
   PubMed Web of Science ®Google Scholar
• Rubin HA, Bruce S, Rosen T, McBride ME. Evidence for percutaneous inoculation as the mode of transmission for chromoblastomycosis. J Am Acad Dermatol 1991; 25: 951–954
   PubMedGoogle Scholar
• Salgado CG, da Silva JP, Diniz JA, et al. Isolation of Fonsecaea pedrosoi from thorns of Mimosa pudica, a probable natural source of chromoblastomycosis. Rev Inst Med Trop Sao Paulo 2004; 46: 33–36
   PubMedGoogle Scholar
• Arango M, Jaramillo C, Cortes A, Restrepo A. Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa. Med Mycol 1998; 36: 43–45
   PubMed Web of Science ®Google Scholar
• Londero AT, Ramos CD, Fischman O, et al. Primary chromoblastomycosis of the nose. Hospital (Rio J) 1968; 74: 625–630
   Google Scholar
• Zaror L, Fischman O, Pereira CA, et al. A case of primary nasal chromoblastomycosis. Mykosen 1987; 30: 468–471
   Google Scholar
• Ogawa MM, Alchorne MM, Barbieri A, et al. Lymphoscintigraphic analysis in chromoblastomycosis. Int J Dermatol 2003; 42: 622–625
   PubMedGoogle Scholar
• Takase T, Baba T, Uyeno K. Chromomycosis. A case with a widespread rash, lymph node metastasis and multiple subcutaneous nodules. Mycoses 1988; 31: 343–352
   PubMedGoogle Scholar
• Pardo-Castelo V, Leon R, Trespalacios F. Chromoblastomycosis in Cuba. Arch Dermatol Syphilography 1942; 65: 19–32
   Google Scholar
• Lavalle P. Chromomycosis. In Canizare O.. Clinical Tropical Dermatology. London: Blackwell Scientific Publications; 1975: 36–41.
   Google Scholar
• Carrion AL. Chromoblastomycosis. Ann N Y Acad Sci 1950; 50: 1255–1282
   PubMedGoogle Scholar
• Queiroz-Telles F, Purim KS, Fillus JN, et al. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol 1992; 31: 805–812
   PubMed Web of Science ®Google Scholar
• Restrepo A, Gonzalez A, Gomez I, Arango M, de BC. Treatment of chromoblastomycosis with itraconazole. Ann N Y Acad Sci 1988; 544: 504–516
   PubMedGoogle Scholar
• Esterre P, Pecarrere JL, Raharisolo C, Huerre M. Esquamous cell carcinoma arising from chromomycosis. Report of two cases]. Ann Pathol 1999; 19: 516–520
   PubMedGoogle Scholar
• Foster HM, Harris TJ. Malignant change (esquamous carcinoma) in chronic chromoblastomycosis. Aust N Z J Surg Oct 1987; 57: 775–757
   Google Scholar
• Zaias N. Chromomycosis. J Cutan Pathol 1978; 5: 155–164
   Google Scholar
• Zaias N, Rebell G. A simple and accurate diagnostic method in chromoblastomycosis. Arch Dermatol 1973; 108: 545–546
   Google Scholar
• Lee MW, Hsu S, Rosen T. Spores and mycelia in cutaneous chromomycosis. J Am Acad Dermatol 1998; 39: 850–852
   PubMedGoogle Scholar
• Salfelder K, de Liscano TR, Sauerteig E. Atlas of Fungal Pathology Kluwer/Dordrecht; 1990:145–50.
   Google Scholar
• Correa GP, d'Avila S, Pagliari C, Duarte MIS. The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease. Mycopathologia 2002; 156: 51–60
   Google Scholar
• Padhye AA, Hampton AA, Hampton MT, et al. Chromoblastomycosis caused by Exophiala spinifera. Clin Infect Dis 1996; 22: 331–335
   PubMed Web of Science ®Google Scholar
• de Andrade TS, Cury AE, de Castro LG, Hirata MH, Hirata RD. Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis. Diagn Microbiol Infect Dis 2007; 57: 267–272
   Google Scholar
• Abliz P, Fukushima K, Takizawa K, Nishimura K. Specific oligonucleotide primers for identification of Cladophialophora carrionii, a causative agent of chromoblastomycosis. J Clin Microbiol 2004; 42: 404–407
   PubMed Web of Science ®Google Scholar
• Esterre P, Jahevitra M, Andriantsimahavandy A. Humoral immune response in chromoblastomycosis during and after therapy. Clin Diagn Lab Immunol 2000; 7: 497–500
   PubMedGoogle Scholar
• Vidal MS, de Castro LG, Cavalecate SC, Lacaz CS. Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis. Rev Inst Med Trop Sao Paulo 2003; 45: 315–318
   Google Scholar
• Vidal MS, Castro LG, Cavalcante SC, Lacaz CS. Highly specific and sensitive, immunoblot-detected 54 kDa antigen from Fonsecaea pedrosoi. Med Mycol 2004; 42: 511–515
   PubMed Web of Science ®Google Scholar
• Oberto-Perdigon L, Romero H, Perez-Blanco M, Pitz-Castro R. An ELISA test for the study of the therapeutic evolution of chromoblastomycosis by Cladophialophora carrionii in the endemic area of Falcon State, Venezuela]. Rev Iberoam Micol 2005; 22: 39–43
   PubMedGoogle Scholar
• Castro LG. Chromomycosis: a therapeutic challenge. Clin Infect Dis 1992; 15: 553–554
   PubMedGoogle Scholar
• Restrepo A. Treatment of tropical mycoses. J Am Acad Dermatol 1994; 31: S91–S102
   PubMed Web of Science ®Google Scholar
• Hazen KC. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison. J Am Acad Dermatol 1998; 38: S37–S41
   PubMed Web of Science ®Google Scholar
• McGinnis MR, Pasarell L. In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Med Mycol 1998; 36: 243–246
   PubMed Web of Science ®Google Scholar
• Andrade TS, Castro LG, Nunes RS, et al. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Mycoses 2004; 47: 216–221
   PubMed Web of Science ®Google Scholar
• McBurney EI. Chromoblastomycosis treatment with ketoconazole. Cutis 1982; 30: 746–748
   Google Scholar
• Olle-Goig JE, Domingo J. A case of chromomycosis treated with thiabendazole. Trans R Soc Trop Med Hyg 1983; 77: 773–774
   Google Scholar
• McGinnis MR, Pasarell L. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J Clin Microbiol 1998; 36: 2353–2355
   PubMed Web of Science ®Google Scholar
• Bonifaz A, Saul A, Paredes-Solis V, Araiza J, Fierro-Arias L. Treatment of chromoblastomycosis with terbinafine: experience with four cases. J Dermatolog Treat 2005; 16: 47–51
   PubMed Web of Science ®Google Scholar
• Esterre P, Inzan CK, Ramarcel ER, et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol 1996; 134(Suppl. 46)33–36
   PubMedGoogle Scholar
• Xibao Z, Changxing L, Quan L, Yuqing H. Treatment of chromoblastomycosis with terbinafine: a report of four cases. J Dermatolog Treat 2005; 16: 121–124
   PubMed Web of Science ®Google Scholar
• Gupta AK, Taborda PR, Sanzovo AD. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Med Mycol 2002; 40: 529–534
   PubMed Web of Science ®Google Scholar
• Pradinaud R , Bolzinger T. Treatment of chromoblastomycosis. J Am Acad Dermatol 199; 25: 869–870.
   Google Scholar
• Grant SM, Clissold SP. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989; 37: 310–344
   PubMed Web of Science ®Google Scholar
• Queiroz-Telles F, Purim KS, Boguszewski CL, et al. Adrenal response to corticotrophin and testosterone during long-term therapy with itraconazole in patients with chromoblastomycosis. J Antimicrob Chemother 1997; 40: 899–902
   Google Scholar
• Esterre P, Risteli L, Ricard-Blum S. Immunohistochemical study of type I collagen turn-over and of matrix metalloproteinases in chromoblastomycosis before and after treatment by terbinafine. Pathol Res Pract 1998; 194: 847–853
   PubMedGoogle Scholar
• Bonifaz A, Paredes-Solis V, Saul A. Treating chromoblastomycosis with systemic antifungals. Expert Opin Pharmacother 2004; 5: 247–254
   PubMed Web of Science ®Google Scholar
• Arenas R. Chromoblastomycosis. In: Jacobs PHNL. Antifungal Drug Therapy: A Complete Guide for the Practitioner. New York: Marcel-Dekker; 1990: 43–50.
   Google Scholar
• Pavlidakey GP, Snow SN, Mohs FE. Chromoblastomycosis treated by Mohs micrographic surgery. J Dermatol Surg Oncol 1986; 12: 1073–1075
   PubMedGoogle Scholar
• Hira K, Yamada H, Takahashi Y, Ogawa H. Successful treatment of chromomycosis using carbon dioxide laser associated with topical heat applications. J Eur Acad Dermatol Venereol 2002; 16: 273–275
   PubMed Web of Science ®Google Scholar
• Kuttner BJ, Siegle RJ. Treatment of chromomycosis with a CO2 laser. J Dermatol Surg Oncol 1986; 12: 965–968
   PubMedGoogle Scholar
• Tagami H, Ohi M, Aoshima T, Moriguchi M, et al. Topical heat therapy for cutaneous chromomycosis. Arch Dermatol 1979; 115: 740–741
   PubMedGoogle Scholar
• Tagami H, Ginoza M, Imaizumi S, et al. Successful treatment of chromoblastomycosis with topical heat therapy. J Am Acad Dermatol 1984; 10: 615–619
   PubMed Web of Science ®Google Scholar
• Yanase K, Yamada M. Pocket-warmer’ therapy of chromomycosis [letter]. Arch Dermatol 1978; 114: 1095
   PubMedGoogle Scholar
• Hiruma M, Kawada A, Yoshida M, Kouya M. Hyperthermic treatment of chromomycosis with disposable chemical pocket warmers. Report of a successfully treated case, with a review of the literature. Mycopathologia 1993; 122: 107–114
   Google Scholar
• Bonifaz A, Martinez-Soto E, Carrasco-Gerard E, Peniche J. Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both. Int J Dermatol 1997; 36: 542–547
   PubMed Web of Science ®Google Scholar
• Kullavanijaya P, Rojanavanich V. Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy. Int J Dermatol 1995; 34: 804–807
   PubMed Web of Science ®Google Scholar
• Castro LG, Pimentel ER, Lacaz CS. Treatment of chromomycosis by cryosurgery with liquid nitrogen: 15 years’ experience. Int J Dermatol 2003; 42: 408–412
   PubMed Web of Science ®Google Scholar
• Bopp C. Therapy of chromoblastomycosis with a new method]. Med Cutan Ibero Lat Am 1976; 4: 285–292
   PubMedGoogle Scholar
• Kumarasinghe SP, Kumarasinghe MP. Itraconazole pulse therapy in chromoblastomycosis. Eur J Dermatol 2000; 10: 220–222
   PubMed Web of Science ®Google Scholar
• Tanuma H, Hiramatsu M, Mukai H, et al. Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan. Mycoses 2000; 43: 79–83
   PubMedGoogle Scholar
• Hay RJ. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br J Dermatol 1999; 56: 36–40
   Google Scholar
• Sevigny GM, Ramos-Caro FA. Treatment of chromoblastomycosis due to Fonsecaea pedrosoi with low-dose terbinafine. Cutis 2000; 66: 45–46
   PubMed Web of Science ®Google Scholar
• Shear N, Drake L, Gupta AK, Lambert J, Yaniv R. The implications and management of drug interactions with itraconazole, fluconazole and terbinafine. Dermatology 2000; 201: 196–203
   PubMed Web of Science ®Google Scholar
• Perez-Blanco M, Hernández Valles R, Zeppenfeldt GF, Apitz-Castro R. Ajoene and 5-fluorouracil in the topical treatment of Cladophialophora carrionii chromoblastomycosis in humans: a comparative open study. Med Mycol 2003; 41: 517–520
   PubMed Web of Science ®Google Scholar
• Negroni R, Tobon A, Bustamante B, et al. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 2005; 47: 339–346
   PubMedGoogle Scholar